LAB
STANDARD BIOTOOLS INC.
Nasdaq Pharmaceutical Preparations Accelerated filer

Key Financials

Net Income
$-74896000
↑ 46.1%
Gross Profit
$42.5M
↓ 49.5%
Revenue
$85.3M
↓ 51.1%
Operating Income
$-110249000
↑ 37.1%
Total Assets
$567.8M
↓ 7.3%
EPS (Diluted)
$-0.20
↑ 61.5%
Total Liabilities
$143.5M
↑ 2.0%
Cash & Equivalents
$120.9M
↓ 27.5%

Recent SEC Filings

Form Type Filed Date Link
SCHEDULE 13G/A 8/14/2026 View on SEC
SCHEDULE 13G 8/14/2026 View on SEC
S-8 8/5/2026 View on SEC
S-8 8/5/2026 View on SEC
10-Q 8/5/2026 View on SEC
8-K 8/5/2026 View on SEC
4 8/4/2026 View on SEC
SCHEDULE 13G/A 7/30/2026 View on SEC
425 7/29/2026 View on SEC
8-K/A 7/29/2026 View on SEC

Company Information

Field Value
Ticker LAB
Company Name STANDARD BIOTOOLS INC.
CIK 1162194
Sector Pharmaceutical Preparations
Industry Accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 6502666000